FdaApplication
ANDA 205323
Identifiers
- fda_app_no: ANDA205323
Properties
| Property | Value |
|---|---|
| applicant_name | GLAND PHARMA LTD |
| application_type | ANDA |
| approval_date | 2017-02-06 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HEPARIN SODIUM | HEPARIN SODIUM | 1,000 UNITS/ML | INJECTABLE;INJECTION |
| HEPARIN SODIUM | HEPARIN SODIUM | 5,000 UNITS/ML | INJECTABLE;INJECTION |
2 products